Beneficial effects of prophylactic OKT3 in cadaver kidney transplantation: comparison with cyclosporin A in a single-center prospective randomized study

Transplant Proc. 1991 Feb;23(1 Pt 2):1046-7.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Cadaver
  • Cyclosporins / therapeutic use*
  • Graft Survival
  • Humans
  • Immunosuppression Therapy / methods*
  • Kidney Transplantation / methods*
  • Muromonab-CD3
  • Prospective Studies

Substances

  • Antibodies, Monoclonal
  • Cyclosporins
  • Muromonab-CD3